Global and United States Ventriculo-Peritoneal Hydrocephalus Shunts Market Report & Forecast 2023-2029

Report ID: ARS2011 | Category: Healthcare | Pages: 128 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$4350.00 Multi User-$6300.00

Report Description
View Table of Contents

Report Summary

The research time span covered by the report is from 2018 to 2029; it provides an overview of the Global Ventriculo-Peritoneal Hydrocephalus Shunts Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.

The global Ventriculo-Peritoneal Hydrocephalus Shunts market size in 2022 is XX million US dollars, and it is expected to be 600.4 million US dollars by 2029, with a compound annual growth rate of 4.80% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Ventriculo-Peritoneal Hydrocephalus Shunts market include Boston Neurosciences (U.S.), TKB Corporation (Japan), HLL Lifecare Limited (India), Christoph Miethke GmbH & Co. KG (Germany), and Integra LifeSciences (U.S.). The share of the top 3 players in the Ventriculo-Peritoneal Hydrocephalus Shunts market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Ventriculo-Peritoneal Hydrocephalus Shunts market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Hydrocephalus Valves accounted for XX% of Ventriculo-Peritoneal Hydrocephalus Shunts market in 2022. Adjustable Pressure Valves share of XX%.
Hospitals accounted for XX% of the Ventriculo-Peritoneal Hydrocephalus Shunts market in 2022. Ambulatory Surgical Centers accounts for XX%.

For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.

As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.

Key Factors Considered:
COVID-19
The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.

Regional Conflict / Russia-Ukraine War
The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it's going to evolve in the years to come.

Challenges & Opportunities
Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Highlights-Regions

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Argentina
Mexico
MEA
Saudi Arabia
UAE
Turkey

Player list
Boston Neurosciences (U.S.)
TKB Corporation (Japan)
HLL Lifecare Limited (India)
Christoph Miethke GmbH & Co. KG (Germany)
Integra LifeSciences (U.S.)
Sophysa SA (France)
Spiegelberg GmbH & Co. KG (Germany)
Terumo Corporation (Japan)
Natus Medical Incorporated (U.S.)
Braun Melsungen AG (Germany)
Medtronic (Ireland)
Johnson & Johnson Services Inc. (U.S.)
HpBio Próteses, Inc. (U.S.)
Kaneka Medix Corporation (Japan)

Types list
Hydrocephalus Valves
Adjustable Pressure Valves
Fix Pressure Valves
Hydrocephalus Catheters

Application list
Hospitals
Ambulatory Surgical Centers

Table of Content

1 Study Coverage
1.1 Ventriculo-Peritoneal Hydrocephalus Shunts Product Introduction
1.2 Global Ventriculo-Peritoneal Hydrocephalus Shunts Outlook 2018 VS 2023 VS 2029
1.3 United States Ventriculo-Peritoneal Hydrocephalus Shunts Outlook 2018 VS 2023 VS 2029
1.4 Ventriculo-Peritoneal Hydrocephalus Shunts Market Size, United States VS Global, 2018-2029
1.4.1 The Market Share of United States Ventriculo-Peritoneal Hydrocephalus Shunts in Global, 2018-2029
1.4.2 The Growth Rate of Ventriculo-Peritoneal Hydrocephalus Shunts Market Size, United States VS Global, 2018 VS 2023 VS 2029
1.5 Ventriculo-Peritoneal Hydrocephalus Shunts Market Dynamics
1.5.1 Ventriculo-Peritoneal Hydrocephalus Shunts Market Trends
1.5.2 Ventriculo-Peritoneal Hydrocephalus Shunts Market Drivers
1.5.3 Ventriculo-Peritoneal Hydrocephalus Shunts Market Challenges
1.5.4 Ventriculo-Peritoneal Hydrocephalus Shunts Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Coronavirus Disease (COVID-19) Impact on Global
2 Global Ventriculo-Peritoneal Hydrocephalus Shunts Competitor Landscape by Company
2.1 Global Ventriculo-Peritoneal Hydrocephalus Shunts Market Size by Company
2.1.1 Top Global Ventriculo-Peritoneal Hydrocephalus Shunts Player Ranked by Revenue (2023)
2.1.2 Global Ventriculo-Peritoneal Hydrocephalus Shunts Revenue by Player (2018-2023)
2.2 Global Ventriculo-Peritoneal Hydrocephalus Shunts Concentration Ratio (CR)
2.2.1 Ventriculo-Peritoneal Hydrocephalus Shunts Market Concentration Ratio (CR) (2018-2023)
2.2.2 Global Top 3 and Top 6 Largest Players of Ventriculo-Peritoneal Hydrocephalus Shunts in 2023
2.3 Global Ventriculo-Peritoneal Hydrocephalus Shunts Business Distribution, Business Type
2.3.1 Global Ventriculo-Peritoneal Hydrocephalus Shunts Players, Headquarters and Distribution
2.3.2 Players Ventriculo-Peritoneal Hydrocephalus Shunts Business Type
2.3.3 Date of International Players Enter into Ventriculo-Peritoneal Hydrocephalus Shunts Market
2.4 Players Mergers & Acquisitions, Expansion Plans
2.5 United States Ventriculo-Peritoneal Hydrocephalus Shunts Market Size by Company
2.5.1 Top United States Ventriculo-Peritoneal Hydrocephalus Shunts Player s Ranked by Revenue (2023)
2.5.2 United States Ventriculo-Peritoneal Hydrocephalus Shunts Revenue by Player (2018-2023)
3 Ventriculo-Peritoneal Hydrocephalus Shunts Market Segment by Type
3.1 Ventriculo-Peritoneal Hydrocephalus Shunts Market Segment by Type
3.2 Global Ventriculo-Peritoneal Hydrocephalus Shunts Market Size by Type
3.3 United States Ventriculo-Peritoneal Hydrocephalus Shunts Market Size by Type
4 Ventriculo-Peritoneal Hydrocephalus Shunts by Market Segment Application
4.1 Ventriculo-Peritoneal Hydrocephalus Shunts Market Segment by Application
4.2 Global Ventriculo-Peritoneal Hydrocephalus Shunts Market Size by Application
4.3 United States Ventriculo-Peritoneal Hydrocephalus Shunts Market Size by Application
5 Global Ventriculo-Peritoneal Hydrocephalus Shunts Market Size by Region
5.1 Global Ventriculo-Peritoneal Hydrocephalus Shunts Market Size by Region: 2018 VS 2023 VS 2029
5.2 Global Ventriculo-Peritoneal Hydrocephalus Shunts Market Size in Value by Region (2018-2029)
5.2.1 Global Ventriculo-Peritoneal Hydrocephalus Shunts Revenue by Region: 2018-2023
5.2.2 Global Ventriculo-Peritoneal Hydrocephalus Shunts Revenue by Region: 2023-2029
6 Segment in Regional Level & Country Level
6.1 North America
6.1.1 North America Ventriculo-Peritoneal Hydrocephalus Shunts Market Size YoY Growth 2018-2029
6.1.2 North America Ventriculo-Peritoneal Hydrocephalus Shunts Market Facts & Figures by Country (2018-2029)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia Pacific
6.2.1 Asia Pacific Ventriculo-Peritoneal Hydrocephalus Shunts Market Size YoY Growth 2018-2029
6.2.2 Asia Pacific Ventriculo-Peritoneal Hydrocephalus Shunts Market Facts & Figures by Country (2018-2029)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Southeast Asia
6.3 Europe
6.3.1 Europe Ventriculo-Peritoneal Hydrocephalus Shunts Market Size YoY Growth 2018-2029
6.3.2 Europe Ventriculo-Peritoneal Hydrocephalus Shunts Market Facts & Figures by Country (2018-2029)
6.3.3 Germany
6.3.4 France
6.3.5 UK
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Ventriculo-Peritoneal Hydrocephalus Shunts Market Size YoY Growth 2018-2029
6.4.2 Latin America Ventriculo-Peritoneal Hydrocephalus Shunts Market Facts & Figures by Country (2018-2029)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Ventriculo-Peritoneal Hydrocephalus Shunts Market Size YoY Growth 2018-2029
6.5.2 Middle East and Africa Ventriculo-Peritoneal Hydrocephalus Shunts Market Facts & Figures by Country (2018-2029)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1  Boston Neurosciences (U.S.)
7.1.1 Company Details
7.1.2 Description and Business Overview
7.1.3 Ventriculo-Peritoneal Hydrocephalus Shunts Introduction
7.1.4 Boston Neurosciences (U.S.) Ventriculo-Peritoneal Hydrocephalus Shunts Revenue, Gross, and Gross Margin (2018-2023)
7.1.5 Boston Neurosciences (U.S.) Recent Development
7.2  TKB Corporation (Japan)
7.2.1 Company Details
7.2.2 Description and Business Overview
7.2.3 Ventriculo-Peritoneal Hydrocephalus Shunts Introduction
7.2.4 TKB Corporation (Japan) Ventriculo-Peritoneal Hydrocephalus Shunts Revenue, Gross, and Gross Margin (2018-2023)
7.2.5 TKB Corporation (Japan) Recent Development
7.3  HLL Lifecare Limited (India)
7.3.1 Company Details
7.3.2 Description and Business Overview
7.3.3 Ventriculo-Peritoneal Hydrocephalus Shunts Introduction
7.3.4 HLL Lifecare Limited (India) Ventriculo-Peritoneal Hydrocephalus Shunts Revenue, Gross, and Gross Margin (2018-2023)
7.3.5 HLL Lifecare Limited (India) Recent Development
7.4  Christoph Miethke GmbH & Co. KG (Germany)
7.4.1 Company Details
7.4.2 Description and Business Overview
7.4.3 Ventriculo-Peritoneal Hydrocephalus Shunts Introduction
7.4.4 Christoph Miethke GmbH & Co. KG (Germany) Ventriculo-Peritoneal Hydrocephalus Shunts Revenue, Gross, and Gross Margin (2018-2023)
7.4.5 Christoph Miethke GmbH & Co. KG (Germany) Recent Development
7.5  Integra LifeSciences (U.S.)
7.5.1 Company Details
7.5.2 Description and Business Overview
7.5.3 Ventriculo-Peritoneal Hydrocephalus Shunts Introduction
7.5.4 Integra LifeSciences (U.S.) Ventriculo-Peritoneal Hydrocephalus Shunts Revenue, Gross, and Gross Margin (2018-2023)
7.5.5 Integra LifeSciences (U.S.) Recent Development
7.6  Sophysa SA (France)
7.6.1 Company Details
7.6.2 Description and Business Overview
7.6.3 Ventriculo-Peritoneal Hydrocephalus Shunts Introduction
7.6.4 Sophysa SA (France) Ventriculo-Peritoneal Hydrocephalus Shunts Revenue, Gross, and Gross Margin (2018-2023)
7.6.5 Sophysa SA (France) Recent Development
7.7  Spiegelberg GmbH & Co. KG (Germany)
7.7.1 Company Details
7.7.2 Description and Business Overview
7.7.3 Ventriculo-Peritoneal Hydrocephalus Shunts Introduction
7.7.4 Spiegelberg GmbH & Co. KG (Germany) Ventriculo-Peritoneal Hydrocephalus Shunts Revenue, Gross, and Gross Margin (2018-2023)
7.7.5 Spiegelberg GmbH & Co. KG (Germany) Recent Development
7.8  Terumo Corporation (Japan)
7.8.1 Company Details
7.8.2 Description and Business Overview
7.8.3 Ventriculo-Peritoneal Hydrocephalus Shunts Introduction
7.8.4 Terumo Corporation (Japan) Ventriculo-Peritoneal Hydrocephalus Shunts Revenue, Gross, and Gross Margin (2018-2023)
7.8.5 Terumo Corporation (Japan) Recent Development
7.9  Natus Medical Incorporated (U.S.)
7.9.1 Company Details
7.9.2 Description and Business Overview
7.9.3 Ventriculo-Peritoneal Hydrocephalus Shunts Introduction
7.9.4 Natus Medical Incorporated (U.S.) Ventriculo-Peritoneal Hydrocephalus Shunts Revenue, Gross, and Gross Margin (2018-2023)
7.9.5 Natus Medical Incorporated (U.S.) Recent Development
7.10  Braun Melsungen AG (Germany)
7.10.1 Company Details
7.10.2 Description and Business Overview
7.10.3 Ventriculo-Peritoneal Hydrocephalus Shunts Introduction
7.10.4 Braun Melsungen AG (Germany) Ventriculo-Peritoneal Hydrocephalus Shunts Revenue, Gross, and Gross Margin (2018-2023)
7.10.5 Braun Melsungen AG (Germany) Recent Development
7.11  Medtronic (Ireland)
7.11.1 Company Details
7.11.2 Description and Business Overview
7.11.3 Ventriculo-Peritoneal Hydrocephalus Shunts Introduction
7.11.4 Medtronic (Ireland) Ventriculo-Peritoneal Hydrocephalus Shunts Revenue, Gross, and Gross Margin (2018-2023)
7.11.5 Medtronic (Ireland) Recent Development
7.12  Johnson & Johnson Services Inc. (U.S.)
7.12.1 Company Details
7.12.2 Description and Business Overview
7.12.3 Ventriculo-Peritoneal Hydrocephalus Shunts Introduction
7.12.4 Johnson & Johnson Services Inc. (U.S.) Ventriculo-Peritoneal Hydrocephalus Shunts Revenue, Gross, and Gross Margin (2018-2023)
7.12.5 Johnson & Johnson Services Inc. (U.S.) Recent Development
7.13  HpBio Próteses, Inc. (U.S.)
7.13.1 Company Details
7.13.2 Description and Business Overview
7.13.3 Ventriculo-Peritoneal Hydrocephalus Shunts Introduction
7.13.4 HpBio Próteses, Inc. (U.S.) Ventriculo-Peritoneal Hydrocephalus Shunts Revenue, Gross, and Gross Margin (2018-2023)
7.13.5 HpBio Próteses, Inc. (U.S.) Recent Development
7.14  Kaneka Medix Corporation (Japan)
7.14.1 Company Details
7.14.2 Description and Business Overview
7.14.3 Ventriculo-Peritoneal Hydrocephalus Shunts Introduction
7.14.4 Kaneka Medix Corporation (Japan) Ventriculo-Peritoneal Hydrocephalus Shunts Revenue, Gross, and Gross Margin (2018-2023)
7.14.5 Kaneka Medix Corporation (Japan) Recent Development
8 Value Chain and Sales Channels Analysis
8.1 Ventriculo-Peritoneal Hydrocephalus Shunts Value Chain Analysis
8.2 Ventriculo-Peritoneal Hydrocephalus Shunts Customers
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology
10.1.1 Research Process
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Legal Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global and United States Ventriculo-Peritoneal Hydrocephalus Shunts Market Report & Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?